Comment on ‘Systematic Druggable Genome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Sarcopenia’ by Yin et al.—The Author's Reply

Yin, Kang‐Fu; Chen, Yong‐Ping

doi:10.1002/jcsm.13652

J cachexia sarcopenia muscle

2024

DOI: 10.1002/jcsm.13652

|View full text |Cite

Comment on ‘Systematic Druggable Genome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Sarcopenia’ by Yin et al.—The Author's Reply

Kang‐Fu Yin,

Yong‐Ping Chen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Exploring the associations of plasma proteins with frailty based on Mendelian randomization

Chen,

Lin,

Liu

et al. 2024

BMC Immunol

View full text Add to dashboard Cite

Background Frailty is an emerging global burden of disease, characterized as an age-related clinical syndrome. Recent studies have suggested a potential link of circulating protein levels with the onset of frailty. This study aims to analyze the potential causal relationships of plasma proteins with frailty using a Mendelian Randomization (MR) study design. Methods Associations of plasma proteins with frailty were assessed using inverse variance weighted (IVW), MR-Egger regression, weighted median, maximum-likelihood method, and MR-PRESSO test. Protein-protein interaction network construction and gene ontology functional enrichment analysis were conducted based on MR-identified target proteins. Results After false discovery rate (FDR) correction, MR analysis identified five plasma proteins, including BIRC2 [OR = 0.978, 95%CI (0.967–0.990)] and PSME1 [OR = 0.936, 95%CI (0.909–0.965)], as protective factors against frailty, and 49 proteins, including APOB [OR = 1.053, 95%CI (1.037–1.069)] and CYP3A4 [OR = 1.098, 95%CI (1.068–1.128)], as risk factors. Network analysis suggested BIRC2, PSME1, APOE, and CTNNB1 as key intervention targets. Conclusion This study employed MR design to investigate the association of circulating plasma proteins with frailty, identified five proteins negatively associated with frailty risk and 49 proteins positively associated with frailty. Supplementary Information The online version contains supplementary material available at 10.1186/s12865-024-00677-1.

show abstract

Exploring the associations of plasma proteins with frailty based on Mendelian randomization

Chen,

Lin,

Liu

et al. 2024

BMC Immunol

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Comment on ‘Systematic Druggable Genome‐Wide Mendelian Randomization Identifies Therapeutic Targets for Sarcopenia’ by Yin et al.—The Author's Reply

Cited by 1 publication

References 13 publications

Exploring the associations of plasma proteins with frailty based on Mendelian randomization

Exploring the associations of plasma proteins with frailty based on Mendelian randomization

Contact Info

Product

Resources

About